0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > ROR2

ROR2

ROR2 Molecule Information

Name:Tyrosine-protein kinase transmembrane receptor ROR2
Target Synonym:NTRKR2;Neurotrophic tyrosine kinase, receptor-related 2;Tyrosine-protein kinase transmembrane receptor ROR2;ROR2
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase ?

ROR2 Protein Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
Cat. No. Species Product Description Structure Purity Feature
RO2-H82E3 Human Biotinylated Human ROR2 / NTRKR2 Protein, His,Avitag™
RO2-H82E3-structure
RO2-H82E3-sds
RO2-M5253 Mouse Mouse ROR2 / NTRKR2 Protein, Fc Tag
RO2-M5253-structure
RO2-M5253-sds
RO2-H52E5 Human Human ROR2 / NTRKR2 Protein, His Tag
RO2-H52E5-structure
RO2-H52E5-sds
RO2-H5251 Human Human ROR2 / NTRKR2 Protein, Fc Tag
RO2-H5251-structure
RO2-H5251-sds

ROR2 Molecule Synonym Name

ROR2,NTRKR2

ROR2 Molecule Background

Tyrosine-protein kinase transmembrane receptor ROR2 is also known as Neurotrophic tyrosine kinase, receptor-related 2 (NTRKR2), which belongs to the protein kinase superfamily and Tyr protein kinase family and ROR subfamily. ROR2 is a homodimer protein, which can binds YWHAB or interact with WTIP. ROR2 may be involved in the early formation of the chondrocytes. It seems to be required for cartilage and growth plate development.

ROR2 References

ROR2 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
CCT301-38 CCT301-38; CCT301-38 AXL,CCT301 38; CCT301 38 AXL Phase Ⅱ BioAtla, F1 Oncology, Shanghai PerHum Therapeutics Renal cell carcinoma Details
BA-3021 CAB-ROR2-ADC; BA-3021; CAB-ADC; CAB-ROR2 Phase Ⅱ BioAtla Triple negative breast cancer, Non small cell lung cancer (NSCLC), Solid tumours, Soft tissue sarcoma Details

This web search service is supported by Google Inc.

totop